Engin Ulukaya Selected Research

Engin Ulukaya Research Topics

Disease

45	Neoplasms (Cancer) 05/2022 - 04/2004
30	Breast Neoplasms (Breast Cancer) 06/2021 - 12/2009
11	Lung Neoplasms (Lung Cancer) 09/2021 - 09/2006
10	Non-alcoholic Fatty Liver Disease 01/2011 - 02/2007
8	Necrosis 01/2021 - 11/2007
6	Prostatic Neoplasms (Prostate Cancer) 11/2020 - 01/2013
6	Carcinoma (Carcinomatosis) 10/2017 - 06/2007
5	Neoplasm Metastasis (Metastasis) 05/2022 - 12/2011
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 10/2011
3	Colonic Neoplasms (Colon Cancer) 08/2018 - 01/2015
3	Liver Diseases (Liver Disease) 11/2009 - 02/2009
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 05/2020
2	Triple Negative Breast Neoplasms 01/2019 - 02/2017
2	Ascites 07/2016 - 03/2015
2	Myocardial Ischemia (Ischemic Heart Diseases) 10/2014 - 12/2009
2	Inflammation (Inflammations) 10/2014 - 12/2010
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2010 - 03/2009
2	Insulin Resistance 01/2010 - 11/2009
2	Fatty Liver 11/2009 - 11/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2009 - 06/2009
2	Infections 04/2009 - 11/2007
1	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019

Drug/Important Bio-Agent (IBA)

17	PalladiumIBA 09/2021 - 10/2011
12	Adenosine Triphosphate (ATP)IBA 05/2022 - 02/2008
11	Keratin-18 (Keratin 18)IBA 01/2021 - 02/2007
10	Pharmaceutical PreparationsIBA 05/2022 - 04/2004
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2007
10	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 10/2010
8	CaspasesIBA 01/2021 - 06/2007
7	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2013
7	PlatinumIBA 01/2019 - 10/2011
5	Proteins (Proteins, Gene)FDA Link 05/2022 - 11/2009
5	5- (2'- naphthyl)- 7- 4- chlorophenyl- (2,3,6,8- tetrahydro)pyrrolo- (3,4- e)(1,4)- diazepine- 6- thioxo- 8- (1H,7H)oneIBA 07/2016 - 10/2011
4	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 06/2011
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017 - 12/2009
3	AntigensIBA 01/2019 - 06/2007
3	Caspase 3 (Caspase-3)IBA 01/2018 - 02/2016
3	MetalsIBA 02/2017 - 11/2014
3	saccharinate(2,2'- 6',2'- terpyridine)palladium(II)IBA 02/2015 - 10/2011
3	Bortezomib (Velcade)FDA Link 01/2015 - 10/2012
2	Histone Deacetylase InhibitorsIBA 01/2021 - 01/2018
2	Propidium (Propidium Iodide)IBA 01/2021 - 01/2018
2	Chloroquine (Aralen)FDA LinkGeneric 01/2021 - 08/2020
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2021 - 01/2018
2	Chalcone (Benzalacetophenone)IBA 06/2020 - 08/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2020 - 01/2020
2	Histones (Histone)IBA 01/2019 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2019 - 11/2007
2	Biological ProductsIBA 01/2018 - 08/2016
2	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 04/2008
2	ImmunosorbentsIBA 08/2016 - 11/2010
2	EnzymesIBA 08/2016 - 11/2010
2	Interleukin-6 (Interleukin 6)IBA 07/2015 - 04/2008
2	Proteasome InhibitorsIBA 01/2015 - 10/2012
2	FenretinideIBA 05/2014 - 07/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2011 - 06/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011 - 09/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2010 - 04/2008
2	Indicators and Reagents (Reagents)IBA 10/2010 - 09/2006
2	Receptor for Advanced Glycation End ProductsIBA 01/2010 - 06/2009
2	Triglycerides (Triacylglycerol)IBA 01/2010 - 11/2009
1	Amino Acids FDA Link 05/2022
1	LipidsIBA 05/2022
1	phenyl di-n-pentylphosphinateIBA 09/2021
1	MicellesIBA 09/2021
1	AcidsIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	Pyruvic Acid (Pyruvate)IBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 11/2020
1	poly-N-isopropylacrylamideIBA 11/2020
1	Antimalarials (Antimalarial Agents)IBA 08/2020
1	barbituric acid (barbiturate)IBA 08/2020
1	protoapigenoneIBA 06/2020
1	ferroceneIBA 06/2020
1	AntioxidantsIBA 01/2020
1	QuercetinIBA 01/2020
1	LigandsIBA 01/2020
1	GlycosidesIBA 03/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Canertinib (CI 1033)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	NaphthoquinonesIBA 01/2019
1	EthaneIBA 08/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	FITC-annexin A5IBA 01/2018
1	celastrol methyl esterIBA 01/2018

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 06/2021 - 06/2007
10	Therapeutics 06/2021 - 06/2007
2	Lasers (Laser) 01/2022 - 01/2009
2	Neoadjuvant Therapy 01/2019 - 06/2011
1	Investigational Therapies (Experimental Therapy) 09/2021
1	Molecular Targeted Therapy 01/2021
1	Radiotherapy 01/2019